Back to Search Start Over

BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR.

Authors :
Kang HJ
Kim HJ
Cho CH
Hu Y
Li R
Bae I
Source :
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2008 Nov; Vol. 62 (6), pp. 965-75. Date of Electronic Publication: 2008 Feb 08.
Publication Year :
2008

Abstract

Purpose: We previously reported that BRCA1 interacts with aryl hydrocarbon receptor nuclear translocator (ARNT) and that this interaction affects TCDD-induced CYP1A1 gene expression (Kang et al., J Biol Chem 281:14654-14662, 2006). In this study we continue this investigation and begin to define the significance of this interaction for the regulation of stress-induced transcription.<br />Methods: Immunoprecipitations (IPs), western blot (WB) analysis, GST pull-down assays and promoter reporter assays were used to investigate whether the aryl hydrocarbon receptor (AhR) can regulate transcription that is dependent on the activation domain 1 (AD1) domain of BRCA1.<br />Results: We show that AhR, a transcription factor, can bind specifically to AD1 in the C-terminal region of BRCA1 and affect BRCA1's ability to regulate transcription activity. We found that xenobiotics that positively and negatively affect AhR's activity as a transcription factor (e.g., dioxin and alpha-naphthoflavone, respectively), have similar effects on AhR's ability to affect AD1-domain-dependent transcription. These physical and functional AhR-AD1 interactions may require the coiled-coil motif in AD1 because point-mutations in this motif reduce these interactions.<br />Conclusion: Xenobiotic-activated AhR can function in two ways, as a component of the AhR/ARNT transcription factor and a regulator of AD1-dependent transcription. Consequently, BRCA1 has two distinct mechanisms for sensing xenobiotics and regulating AhR-dependent stress responses to these xenobiotics. We speculate that the normal functioning of this interaction could play a role in BRCA1's tumor suppressing ability.

Details

Language :
English
ISSN :
1432-0843
Volume :
62
Issue :
6
Database :
MEDLINE
Journal :
Cancer chemotherapy and pharmacology
Publication Type :
Academic Journal
Accession number :
18259752
Full Text :
https://doi.org/10.1007/s00280-008-0686-x